Akoya Biosciences, Inc.

NASDAQ:AKYA

3.17 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 8.92313.03983.12578.59593.32860.24774.22951.83646.88193.938113.079120.15135.46411.69117.006-21.659
Short Term Investments 36.30148.53600006.98929.86840.72500000043.318
Cash and Short Term Investments 45.22461.57583.12578.59593.32860.24781.21881.70487.60693.938113.079120.15135.46411.69117.00621.659
Net Receivables 16.55413.47316.99416.09612.86612.9439.7298.6810.47211.3149.4449.6058.1586.596.470
Inventory 24.79622.98817.87718.75216.13114.50714.48613.06313.21811.3739.0146.0936.5624.7184.2630
Other Current Assets 2.9383.7933.7943.5053.8453.9776.7648.2978.5989.8419.2779.8127.2251.0350.9570
Total Current Assets 89.512101.829121.79116.948126.1791.674112.197111.744119.894126.466140.814145.66157.40924.03428.69621.659
Non-Current Assets:
Property, Plant & Equipment, Net 14.47215.8820.65621.62222.75821.90222.44923.30322.62318.5727.4876.4926.026.0535.5280
Goodwill 18.26218.26218.26218.26218.26218.26218.26218.26218.26218.26218.26218.26218.26218.26218.2620
Intangible Assets 15.98616.69917.41218.12319.12519.49620.04820.44220.79920.9621.1521.37421.64422.1622.7140
Goodwill and Intangible Assets 34.24834.96135.67436.38537.38737.75838.3138.70439.06139.22239.41239.63639.90640.42240.9760
Long Term Investments 4.20.70.6990.330.3230.3040.3030.3020.3020.3020.3020.3010.3010.50200
Tax Assets 00-0-0.33-0.323-0.304-0.303-0.302-0.302-0.302-0.302-0.301-0.301-0.50200
Other Non-Current Assets 1.3131.381.552.2892.5642.9633.0752.7062.6852.5662.8923.3222.7063.472.46-21.659
Total Non-Current Assets 54.23352.92158.57960.29662.70962.62363.83464.71364.36960.66250.09349.75148.93350.44748.964-21.659
Total Assets 143.745154.75180.369177.244188.879154.297176.031176.457184.263187.128190.907195.411206.34274.48177.660
Liabilities & Equity:
Current Liabilities:
Account Payables 9.78510.74711.77625.08426.4622.98327.14722.20924.87511.51823.1984.0714.8985.7765.0740
Short Term Debt 3.3223.3723.4483.5893.7163.5833.6293.5973.5933.1880.2720.2790.2881.5151.2290
Tax Payables 00-63.283-52.459-39.55800000000000
Deferred Revenue 6.4616.6126.6886.857.2146.6576.2795.8765.3154.8924.4844.3544.2874.1163.8440
Other Current Liabilities 13.1712.46213.43300000012.138-0.2728.5968.6889.1517.0150
Total Current Liabilities 32.73833.19335.34535.52337.3933.22337.05531.68233.78331.73627.68217.318.16120.55817.1620
Non-Current Liabilities:
Long Term Debt 75.68475.46975.25471.48471.95571.69272.15562.12952.35240.5332.47132.62532.58333.78733.7650
Deferred Revenue Non-Current 3.172.9283.1932.7822.4952.5452.1141.4771.5541.5191.331.1360.9961.0591.0080
Deferred Tax Liabilities Non-Current 0.0750.0750.0380.0870.0870.0870.0870.1250.1250.0360.0260.1340.1540.160.170
Other Non-Current Liabilities 9.82910.36212.7695.3955.0514.6266.0395.9565.5996.7558.0476.8246.62778.9176.9840
Total Non-Current Liabilities 88.75888.83491.25479.74879.58878.9580.39569.68759.6348.8441.87440.71940.36113.92341.9270
Total Liabilities 121.496122.027126.599115.271116.978112.173117.45101.36993.41380.57669.55658.01958.521134.48159.0890
Equity:
Preferred Stock 266.7140000000000195.411206.3421.2531.25365.6
Common Stock 0.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0010.0020
Retained Earnings -266.704-253.555-230.071-219.269-206.353-185.55-166.748-147.873-130.001-112.506-96.107-78.434-66.817-61.254-52.280
Accumulated Other Comprehensive Income/Loss -0.012-0.0160000-0.006-0.066-0.09200-195.411-206.342-71.55-1.253-31.412
Other Total Stockholders Equity 22.249286.292283.839281.24278.252227.672225.333223.025220.941219.056217.456215.824214.63671.5569.5960
Total Shareholders Equity 22.24932.72353.7761.97371.90142.12458.58175.08890.85106.552121.351137.392147.821-6018.57134.188
Total Equity 22.24932.72353.7761.97371.90142.12458.58175.08890.85106.552121.351137.392147.821-6018.57134.188
Total Liabilities & Shareholders Equity 143.745154.75180.369177.244188.879154.297176.031176.457184.263187.128190.907195.411206.34274.48177.6634.188